ClassID:

96898

C07K14/47 - page 9 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#2401
20170073383
2017-03-16

Chimeric peptide that interacts with cell membrane gangliosides

#2402
20170073381
2017-03-16

Ribosomes with tethered subunits

#2403
20170072011
2017-03-16

Methods of treatment using hemopexin compositions

#2404
20170067112
2017-03-09

Sequences associated with TDP-43 proteinopathies and methods of using the same

#2405
20170066820
2017-03-09

Antibodies specific for sulfation sites of sclerostin

#2406
20170066807
2017-03-09

LIPOCALIN MUTEINS WITH BINDING-AFFINITY FOR GLYPICAN-3 (GPC-3) AND USE OF LIPOCALIN MUTEINS FOR TARGET-SPECIFIC DELIVERY TO CELLS EXPRESSING GPC-3

#2407
20170066806
2017-03-09

Opsin polypeptides and methods of use thereof

#2408
20170065906
2017-03-09

Continuous process for separation of proteins

#2409
20170058361
2017-03-02

Polypeptides and Antibodies for Assessing Predisposition for Myelodysplastic Syndromes or Myelogenous Tumor, and Method for Screening Therapeutic Drugs Therefor

#2410
20170058307
2017-03-02

Eukaryotic cells and methods for recombinantly expressing a product of interest

#2411
20170058028
2017-03-02

APLNR modulators and uses thereof

#2412
20170058009
2017-03-02

Heterogeneous nuclear ribonucleoprotein A2* (hnRNP A2*) and nucleic acid encoding the same

#2413
20170058007
2017-03-02

Self-assembled beta solenoid protein scaffolds

#2414
20170058001
2017-03-02

Composition for organ, tissue, or cell transplantation, kit, and transplantation method

#2415
20170051266
2017-02-23

Antimicrobial agents

#2416
20170049855
2017-02-23

Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases

#2417
20170049854
2017-02-23

Methods for treating myocardial infarction comprising administering sonic hedgehog

#2418
20170049853
2017-02-23

Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

#2419
20170044522
2017-02-16

Mirac proteins

#2420
20170044236
2017-02-16

Integrin Antagonists

#2421
20170044224
2017-02-16

Protein secretory factor with high secretory efficiency and an expression vector comprising the same

#2422
20170044223
2017-02-16

Human Sperm Fibrous Sheath (FS) Proteins: New Target Antigens For Use In Therapeutic Cancer Vaccines And Diagnostic Screening And Methods Of Using Same

#2423
20170043037
2017-02-16

RNA containing modified nucleosides and methods of use thereof

#2424
20170042968
2017-02-16

Isoform nell-1 peptide

#2425
20170037109
2017-02-09

Fibronectin binding domains with reduced immunogenicity

#2426
20170037089
2017-02-09

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

#2427
20170037088
2017-02-09

Extended recombinant polypeptides and compositions comprising same

#2428
20170030898
2017-02-02

Characterization and Directed Evolution of a Methyl Binding Domain Protein for High-Sensitivity DNA Methylation Analysis

#2429
20170029858
2017-02-02

Compositions and methods for making selenocysteine containing polypeptides

#2430
20170029478
2017-02-02

High molecular weight, post-translationally modified protein brushes

#2431
20170029477
2017-02-02

Fusion molecules

#2432
20170028041
2017-02-02

HLA-A2 tumor associated antigen peptides and compositions

#2433
20170022565
2017-01-26

Biomarker pairs for predicting preterm birth

#2434
20170022473
2017-01-26

Method of culturing pluripotent stem cell, and polypeptide to be used therefor

#2435
20170015717
2017-01-19

Methods and compositions comprising tau oligomers

#2436
20170014480
2017-01-19

Peptides derived from NCAPG2 and their use

#2437
20170010285
2017-01-12

Biomarker for parkinson's disease and use thereof

#2438
20170010269
2017-01-12

Methods for detecting levels of pigment epithelium-derived factor and antithrombin-III for characterising and/or prognosing prostate cancer

#2439
20170009250
2017-01-12

Production of Therapeutic Proteins in Photosynthetic Organisms

#2440
20170008939
2017-01-12

Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain

#2441
20170007737
2017-01-12

Amelogenin-chitosan hydrogel for dentin hypersensitivity

#2442
20170002067
2017-01-05

Anti-C5a binding moieties with high blocking activity

#2443
20170002050
2017-01-05

EphA2 T-cell epitope agonists and uses therefore

#2444
20170000827
2017-01-05

Brown adipocyte modification

#2445
20170000768
2017-01-05

Substituted pyrazoles as heat shock transcription factor activators

#2446
20160376556
2016-12-29

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

#2447
20160376549
2016-12-29

Cell culture medium and culture method using the same

#2448
20160376346
2016-12-29

Fc fusion proteins comprising novel linkers or arrangements

#2449
20160376337
2016-12-29

Peptides and compositions for treatment of joint damage

#2450
20160376305
2016-12-29

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

#2451
20160375134
2016-12-29

Modified polynucleotides for the production of secreted proteins

#2452
20160375023
2016-12-29

Methods for treating cancer by inhibiting FGFR3/TACC3 fusion protein

#2453
20160369317
2016-12-22

Protein hydrolysate and method for making a protein hydrolysate

#2454
20160369291
2016-12-22

Colostrum/milk protein compositions

#2455
20160369243
2016-12-22

RNA preparations comprising purified modified RNA for reprogramming cells

#2456
20160368961
2016-12-22

Glycosylated polypeptide and drug composition containing said polypeptide

#2457
20160368956
2016-12-22

Method of preventively treating a subject at the risk of developing infections of a respiratory virus

#2458
20160368955
2016-12-22

Compound, use, anti-tumor pharmaceutical composition, gene construct for polypeptide expression, process for the production, process for the evaluation of tumor cells, method of sensitization of tumor cells to chemotherapeutic

#2459
20160367694
2016-12-22

Peptide having cancer selective translocation function and use thereof

#2460
20160367693
2016-12-22

Selective arylation of dichalcogenides in biomolecules

#2461
20160367690
2016-12-22

CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS

#2462
20160362462
2016-12-15

Modification and compositions of human secretoglobin proteins

#2463
20160362461
2016-12-15

KIDNEY DISEASE TARGETS AND USES THEREOF

#2464
20160362460
2016-12-15

Multi-specific polypeptide useful for localized tumor immunomodulation

#2465
20160362453
2016-12-15

Recombinant binding proteins and their use

#2466
20160361384
2016-12-15

COSMETIC USE OF DERMICIDIN, OR ANALOGUES OR FRAGMENTS THEREOF, FOR THE PREVENTION AND/OR TREATMENT AND DIAGNOSIS OF OILY SKIN AND AESTHETIC SKIN DISORDERS ASSOCIATED THEREWITH

#2467
20160355577
2016-12-08

Methods and compositions for targeting polyubiquitin

#2468
20160355558
2016-12-08

Methods for treatment of nephrotic syndrome and related conditions

#2469
20160355545
2016-12-08

Method for improving protein functionality using vortexing fluid shear forces

#2470
20160354739
2016-12-08

Device and method for production and analysis of prions

#2471
20160354403
2016-12-08

Venule endothelial cell genes and uses thereof

#2472
20160349260
2016-12-01

Methods for detecting expression levels of human signal peptide-containing proteins (HSPP)

#2473
20160347802
2016-12-01

Interaction of draxin and γ-netrins

#2474
20160347800
2016-12-01

Short peptide-based therapeutic agent and medicinal composition including the same for inhibiting activities of cancer cells

#2475
20160346391
2016-12-01

Compositions and methods to modulate cell activity

#2476
20160341744
2016-11-24

Pharmaceutical compositions containing peptides derived from human BPLP protein

#2477
20160340743
2016-11-24

RECURRENT FUSION GENES IDENTIFIED IN HIGH -GRADE SEROUS OVARIAN CARCINOMA

#2478
20160339052
2016-11-24

Wound healing compositions and treatments

#2479
20160338328
2016-11-24

Animal model and cell model developing amyotrophic lateral sclerosis

#2480
20160334418
2016-11-17

Method and means for diagnosing and treating allergy

#2481
20160333063
2016-11-17

SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF

#2482
20160326585
2016-11-10

INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF

#2483
20160324976
2016-11-10

Peptide having cell membrane penetrating activity

#2484
20160324953
2016-11-10

DNA vaccine against virus of Yellow Fever

#2485
20160317616
2016-11-03

Pharmaceutical compositions targeting WNT pathway proteins

#2486
20160316729
2016-11-03

Methods and compositions for generating a mouse

#2487
20160311884
2016-10-27

EGFR-based inhibitor peptides for combinatorial inactivation of ERBB1, ERBB2, and ERBB3

#2488
20160311878
2016-10-27

Three-helix bundle protein and use thereof

#2489
20160311872
2016-10-27

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

#2490
20160311871
2016-10-27

Resistant mutant 90 kDa heat shock protein

#2491
20160311870
2016-10-27

Stable polypeptides binding to human complement C5

#2492
20160304598
2016-10-20

Production cell line enhancers

#2493
20160299153
2016-10-13

Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2

#2494
20160298121
2016-10-13

Targeted augmentation of nuclear gene output

#2495
20160297858
2016-10-13

Dpy-30 binding peptides and methods of use

#2496
20160291474
2016-10-06

Exposure dose homogenization through rotation, translation, and variable processing conditions

#2497
20160291037
2016-10-06

METHODS FOR DETECTING TRAUMATIC BRAIN INJURY

#2498
20160289337
2016-10-06

Polypeptides

#2499
20160289316
2016-10-06

Antibodies that specifcally bind Sost and Wise peptides

#2500
20160289292
2016-10-06

ALK4:ActRIIB heteromultimers and uses thereof

#2501
20160289283
2016-10-06

Selective PYY compounds and uses thereof

#2502
20160289282
2016-10-06

Synthesis of hydantoin containing peptide products

#2503
20160287724
2016-10-06

Compositions and methods for cardiac regeneration

#2504
20160287663
2016-10-06

Methods of treating cancers with peptide-based modulators

#2505
20160282350
2016-09-29

METHODS OF DIAGNOSING CANCER

#2506
20160282347
2016-09-29

Lung cancer diagnosis

#2507
20160281068
2016-09-29

Biocatalysts for ezetimibe synthesis

#2508
20160280760
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2509
20160280759
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2510
20160280758
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2511
20160280757
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2512
20160280753
2016-09-29

Biologically active proteins having increased in vivo and/or in vitro stability

#2513
20160280752
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2514
20160280747
2016-09-29

ANTICALINS

#2515
20160280738
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2516
20160279217
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2517
20160279216
2016-09-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#2518
20160279215
2016-09-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#2519
20160279214
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2520
20160272693
2016-09-22

Amylin analogues

#2521
20160272692
2016-09-22

CDCA1 epitope peptides and vaccines containing the same

#2522
20160271245
2016-09-22

Nucleic acids for treatment of allergies

#2523
20160265000
2016-09-15

Engineered cleavage half-domains for generating nuclease-mediated genomic modifications in a cell

#2524
20160263185
2016-09-15

Modified binding proteins inhibiting the VEGF-A receptor interaction

#2525
20160258934
2016-09-08

Proteasome inhibition assay and methods of use

#2526
20160257730
2016-09-08

Chloroplast expressing colostrum or milk polypeptides

#2527
20160257726
2016-09-08

PROTOXIN-II VARIANTS AND METHODS OF USE

#2528
20160257725
2016-09-08

BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF

#2529
20160257714
2016-09-08

Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 protein

#2530
20160256608
2016-09-08

Scaffold-free self-organized 3D synthetic tissue

#2531
20160256525
2016-09-08

Muteins of tear lipocalin and methods for obtaining the same

#2532
20160251404
2016-09-01

Designed ankyrin repeat proteins binding to hepatocyte growth factor

#2533
20160251386
2016-09-01

Lipid co-factor essential for cell density signaling

#2534
20160250341
2016-09-01

Designed repeat proteins binding to serum albumin

#2535
20160250320
2016-09-01

Immunoregulatory peptides and methods of use

#2536
20160244508
2016-08-25

Use of endostatin peptides for the treatment of fibrosis

#2537
20160244505
2016-08-25

VEGF antagonist formulations suitable for intravitreal administration

#2538
20160244492
2016-08-25

HCBI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for cancer treatment and prevention

#2539
20160244491
2016-08-25

Peptides and compositions for treatment of joint damage

#2540
20160238593
2016-08-18

Pumilio domain-based modular protein architecture for RNA binding

#2541
20160237471
2016-08-18

Method of generating linkage-specific di-and polyprotein probes

#2542
20160237138
2016-08-18

Nucleic acids encoding polypeptides which disrupt D1-D2 dopamine receptor coupling and modulate function

#2543
20160237130
2016-08-18

Apelin fusion proteins and uses thereof

#2544
20160237129
2016-08-18

Mitochondrial targeting and therapeutic use thereof

#2545
20160231248
2016-08-11

Fluorescent protein

#2546
20160229824
2016-08-11

Assay for the detection of the phenylpiperazine family

#2547
20160228499
2016-08-11

Therapy for subarachnoid hemorrhage and ischemia

#2548
20160222454
2016-08-04

Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia

#2549
20160222415
2016-08-04

Nuclear targeting sequences

#2550
20160222119
2016-08-04

Isolated B7-H4 specific compositions and methods of use thereof

#2551
20160222073
2016-08-04

Opsin polypeptides and methods of use thereof

#2552
20160222072
2016-08-04

Universal protein tag for double stranded nucleic acid delivery

#2553
20160221958
2016-08-04

Substituted pyrazoles as heat shock transcription factor activators

#2554
20160220649
2016-08-04

COMBINATIONS OF AGGREGATING PROTEINS AND MOLECULAR CHAPERONE PROTEINS FOR THE TREATMENT OF PROTEINOPATHIES OR CONFORMATIONAL DISEASES

#2555
20160220641
2016-08-04

IL-1beta propeptide and IL-1Ra chimera and methods of using the same

#2556
20160215032
2016-07-28

Influenza nucleoprotein vaccines

#2557
20160215031
2016-07-28

METHOD OF TREATING DISORDERS REQUIRING DESTRUCTION OR REMOVAL OF CELLS

#2558
20160214917
2016-07-28

Fused cyclooctyne compounds and their use in metal-free click reactions

#2559
20160213765
2016-07-28

PLIF multimeric peptides and uses thereof

#2560
20160213745
2016-07-28

USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

#2561
20160213743
2016-07-28

Synthetic apelin fatty acid conjugates with improved half-life

#2562
20160213608
2016-07-28

VEGF antagonist formulations suitable for intravitreal administration

#2563
20160208336
2016-07-21

Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues

#2564
20160207960
2016-07-21

Peptides inhibiting cold-inducible RNA binding protein activity

#2565
20160206692
2016-07-21

Engineered integrin binding peptide compositions

#2566
20160206566
2016-07-21

Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)

#2567
20160200780
2016-07-14

Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same

#2568
20160200765
2016-07-14

Modified mini-hepcidin peptides and methods of using thereof

#2569
20160199513
2016-07-14

Modified polynucleotides for the production of proteins associated with human disease

#2570
20160199443
2016-07-14

Polypeptide targeting to mitochondria

#2571
20160194374
2016-07-07

Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

#2572
20160194367
2016-07-07

Immunogenic peptides and their use in immune disorders

#2573
20160193334
2016-07-07

Treating cancer with a combination of a PD-1 antagonist and dinaciclib

#2574
20160193292
2016-07-07

Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl

#2575
20160186268
2016-06-30

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

#2576
20160186214
2016-06-30

Modified cascade ribonucleoproteins and uses thereof

#2577
20160186152
2016-06-30

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

#2578
20160185863
2016-06-30

Screening method for inhibitors of binding of zBR7R1 to CD155

#2579
20160185834
2016-06-30

Protein engineered systems for delivery of molecules

#2580
20160185833
2016-06-30

Peptides

#2581
20160185832
2016-06-30

Compositions and methods for treatment of disorders related to CEP290

#2582
20160184407
2016-06-30

Class of therapeutic protein based molecules

#2583
20160184393
2016-06-30

Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

#2584
20160178642
2016-06-23

BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS

#2585
20160177400
2016-06-23

RASAL1 is a major tumor suppressor gene in thyroid cancer

#2586
20160177369
2016-06-23

Resonance energy transfer assay with cleavage sequence and spacer

#2587
20160176938
2016-06-23

Partial region polypeptide of REIC/Dkk-3 protein

#2588
20160176934
2016-06-23

Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof

#2589
20160175396
2016-06-23

Methods for treating or preventing fatty liver disease using CTRP3

#2590
20160169906
2016-06-16

METHODS FOR IDENTIFYING AUTOIMMUNE ARTHRITIS AND FOR SCREENING FOR INHIBITOR OF ACTIVATION OF AUTOIMMUNE ARTHRITOGENIC T CELLS

#2591
20160168541
2016-06-16

TRANSDUCIBLE MATERIALS FOR CELL REPROGRAMMING

#2592
20160168269
2016-06-16

Method of treating myocardial infarction by administering a bi-specific fusion protein

#2593
20160168235
2016-06-16

TRANSTHYRETIN AMYLOID-SELECTIVE AND POLYREACTIVE CATABODIES

#2594
20160168212
2016-06-16

COMPOSITIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

#2595
20160168211
2016-06-16

Antibody multimerization technologies

#2596
20160166636
2016-06-16

Methods of treating chronic inflammatory diseases

#2597
20160161494
2016-06-09

Methods and compositions for treating and diagnosing diseases

#2598
20160161486
2016-06-09

Identification, selection and use of high curative potential T cell epitopes

#2599
20160159920
2016-06-09

Coiled coil immunoglobulin fusion proteins and compositions thereof

#2600
20160159871
2016-06-09

Cyclic apelin derivatives for the treatment of heart failure

#2601
20160159870
2016-06-09

Compositions and methods of use for recombinant human secretoglobins

#2602
20160159780
2016-06-09

Strigolactone formulations and uses thereof

#2603
20160158385
2016-06-09

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#2604
20160158330
2016-06-09

METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS

#2605
20160158315
2016-06-09

Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis

#2606
20160157497
2016-06-09

Dispersion and detachment of cell aggregates

#2607
20160152672
2016-06-02

Reagents and methods for treating dental disease

#2608
20160151516
2016-06-02

Modified polynucleotides for the production of proteins

#2609
20160151466
2016-06-02

Botulinum neurotoxins with modified light chain specificity and methods for producing same

#2610
20160146843
2016-05-26

Development and use of cysteine-labeled fluorescent probes of unbound analytes

#2611
20160146801
2016-05-26

NOVEL BIOMARKER DETECTION WITH MOLECULAR IMPRINTS

#2612
20160145312
2016-05-26

CETP antigenic peptide and fusion protein and their composition and applications

#2613
20160145309
2016-05-26

Disulfide cyclic polypeptides for the treatment of heart failure

#2614
20160143994
2016-05-26

Myonectin (CTRP15), compositions comprising same, and methods of use

#2615
20160138115
2016-05-19

METHODS AND CHARACTERISTICS FOR THE DIAGNOSIS OF ACUTE LYMPHOBLASTIC LEUKEMIA

#2616
20160138066
2016-05-19

Methods for the expression of peptides and proteins

#2617
20160137705
2016-05-19

COLON DISEASE TARGETS AND USES THEREOF

#2618
20160130605
2016-05-12

mda-9/syntenin promoter to image and treat metastatic cancer cells

#2619
20160130567
2016-05-12

MESSENGER UNA MOLECULES AND USES THEREOF

#2620
20160130323
2016-05-12

Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment

#2621
20160130313
2016-05-12

Bis-Met histones

#2622
20160130312
2016-05-12

Bis-met histones

#2623
20160129129
2016-05-12

IgG4 Fc fragment comprising modified hinge region

#2624
20160122708
2016-05-05

Small mobile stem cells (SMS) and uses thereof

#2625
20160122413
2016-05-05

Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein

#2626
20160122411
2016-05-05

CARTILAGE-BINDING FUSION PROTEINS

#2627
20160122404
2016-05-05

Compositions and methods for modulation of immune function

#2628
20160122403
2016-05-05

GHRELIN SPLICE VARIANT FOR TREATING NEURONAL DAMAGE,NEURODEGENERATIVE DISEASE, PARKINSONS DISEASE, ALZHEIMERS DISEASE, AND/OR DEPRESSION

#2629
20160122402
2016-05-05

RETRO POLYPEPTIDES FOR ACTIVATION IMMUNITY TO CANCER AND VIRAL INFECTION

#2630
20160122401
2016-05-05

Agents for preventing and treating HIV and other viral infections

#2631
20160120933
2016-05-05

Inhibitors of mitochondrial fission and methods of use thereof

#2632
20160115443
2016-04-28

VP16-CREB fusion gene

#2633
20160115211
2016-04-28

Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)

#2634
20160115210
2016-04-28

Colorimetric and fluorescent proteins

#2635
20160115209
2016-04-28

CERBERUS/COCO DERIVATIVES AND USES THEREOF

#2636
20160114031
2016-04-28

Recombinantly produced allergens

#2637
20160114011
2016-04-28

Modified polynucleotides for the production of nuclear proteins

#2638
20160113996
2016-04-28

TAFA4 compounds and uses thereof for treating pain

#2639
20160108429
2016-04-21

-Prom mediated surface expression of avidin/streptavidin

#2640
20160108404
2016-04-21

Method for inhibiting HIV replication in mammal and human cells

#2641
20160108380
2016-04-21

Fusion proteins and methods thereof

#2642
20160108109
2016-04-21

Antibody against peptide encoded by Exon-21 of periostin and pharmaceutical composition for preventing or treating inflammation-associated diseases containing the same

#2643
20160108099
2016-04-21

Vectors encoding rod-derived cone viability factor

#2644
20160108098
2016-04-21

THERAPEUTIC PEPTIDES

#2645
20160108091
2016-04-21

Cyclic polypeptides for the treatment of heart failure

#2646
20160108087
2016-04-21

Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification

#2647
20160106671
2016-04-21

Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same

#2648
20160102296
2016-04-14

Infectious hepatitis E virus genotype 3 recombinants

#2649
20160102126
2016-04-14

Novel Peptides Involved in Energy Homeostasis

#2650
20160097061
2016-04-07

Viral vectors for the treatment of retinal dystrophy

#2651
20160097042
2016-04-07

Internal protein tags

#2652
20160097031
2016-04-07

Compositions of active Wnt protein

#2653
20160096872
2016-04-07

Methods for producing peptides using engineered inteins

#2654
20160096871
2016-04-07

Methods and Reagents for Treatment of Age-Related Macular Degeneration

#2655
20160091500
2016-03-31

CHONDROADHERIN FRAGMENTS AS INDICATORS OF INTERVERTEBRAL DISC DEGENERATION

#2656
20160091488
2016-03-31

Methods of using U2-OS cells to identify potential sweet taste modulators

#2657
20160083455
2016-03-24

Antiviral agent against animal viruses

#2658
20160083451
2016-03-24

Methods and systems for zinc delivery using intrinsic factor or haptocorrin

#2659
20160083441
2016-03-24

Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect - Cell-Permeable Trefoil Factor 1 (CP-TFF1) in Gastrointestinal Track (GIT) Cancer, Polynucleotides Encoding The Same, and Anti-Cancer Compositions Comprising The Same

#2660
20160083440
2016-03-24

Follistatin in treating duchenne muscular dystrophy

#2661
20160082101
2016-03-24

Horse allergen and methods

#2662
20160082081
2016-03-24

Methods and compositions for treating trinucleotide repeat disorders

#2663
20160082080
2016-03-24

Humanin, analogs and cancer treatment methods and uses thereof

#2664
20160082046
2016-03-24

In vitro production of red blood cells with proteins comprising sortase recognition motifs

#2665
20160076074
2016-03-17

Probes and assays for measuring E3 ligase activity

#2666
20160076011
2016-03-17

Human serum albumin binding compounds and fusion proteins thereof

#2667
20160075767
2016-03-17

Capping modules for designed ankyrin repeat proteins

#2668
20160075748
2016-03-17

Aquaporin-4 Peptide Compositions and Methods of Use

#2669
20160075747
2016-03-17

Method for producing protein

#2670
20160075745
2016-03-17

Mitochondrial proteins constructs and uses thereof

#2671
20160075733
2016-03-17

Modified polynucleotides for the production of biologics and proteins associated with human disease

#2672
20160074475
2016-03-17

CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS

#2673
20160069890
2016-03-10

MOLECULAR LABELING METHODS

#2674
20160068836
2016-03-10

Polynucleotides and polypeptide sequences involved in the process of bone remodeling

#2675
20160068834
2016-03-10

Stablized EZH2 peptides

#2676
20160068579
2016-03-10

Trap 63

#2677
20160068574
2016-03-10

Modified proteins and methods of use thereof

#2678
20160067376
2016-03-10

Bone substitute nanocomposites and methods of synthesis using multiphosphorylated peptides

#2679
20160060637
2016-03-03

Improved Gene Targeting and Nucleic Acid Carrier Molecule, In Particular for Use in Plants

#2680
20160060605
2016-03-03

Frataxin mutants

#2681
20160060332
2016-03-03

Therapeutic DLL4 binding proteins

#2682
20160060309
2016-03-03

ISOLATED CLATHRIN THERAPEUTICS

#2683
20160060308
2016-03-03

Endoplasmic reticulum localization signals

#2684
20160060307
2016-03-03

Human ferritin-derived fusion polypeptide

#2685
20160058857
2016-03-03

Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides

#2686
20160051654
2016-02-25

Immunogenic epitopes for immunotherapy

#2687
20160051623
2016-02-25

Anti-angiogenic peptides and uses thereof

#2688
20160051514
2016-02-25

METHODS FOR TREATMENT OF CARDIOMYOPATHY

#2689
20160046671
2016-02-18

Stabilized SOS1 peptides

#2690
20160046669
2016-02-18

Method for inhibiting proliferation of high LIX1L-expressing tumor cell, and tumor cell proliferation-inhibiting peptide

#2691
20160045494
2016-02-18

Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection

#2692
20160038613
2016-02-11

Delivery of polynucleotides using recombinant AAV9

#2693
20160038576
2016-02-11

Immunogenic compositions for inducing an immune response for elimination of senescent cells

#2694
20160031955
2016-02-04

Methods for Treating Mitochondrial Disorders and Neurodegenerative Disorders

#2695
20160031954
2016-02-04

Water buffalo derived dimeric peptide containing proline for antibiotic therapies

#2696
20160031942
2016-02-04

RHAMM binding peptides

#2697
20160030540
2016-02-04

Immunity inducing agent

#2698
20160024183
2016-01-28

Synthetic peptides for the treatment of autoimmune diseases

#2699
20160024172
2016-01-28

Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof

#2700
20160024170
2016-01-28

Methods of treating damaged cartilage tissue using growth factors fused to heparin binding sequences